SCOPUS 정보 검색 플랫폼

Current Opinion in Biotechnology

Volumn 12, Issue 3, 2001, Pages 317-319

Recent trends in cell substrate considerations for continuous cell lines: Commentary

(2) Lubiniecki, Anthony S a Petricciani, John C b

a GLAXOSMITHKLINE (United States)

b CancerVax Corporation (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAN1 INTERFERON; BIOLOGICAL PRODUCT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RECOMBINANT DNA; TUBERCULIN; VIRUS VACCINE;

ARTICLE; CELL LINE; DNA PURIFICATION; DRUG MANUFACTURE; DRUG SAFETY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0035369780 PISSN: 09581669 EISSN: None Source Type: Journal
DOI: 10.1016/S0958-1669(00)00219-6 Document Type: Note

Times cited : (4)

References (14)

1
- 0004868902
- Background and objectives of the workshop
- Edited by Hopps H, Petricciani, J. Gaithersburg: Tissue Culture Association
- (1985) Abnormal Cells, New Products, and Risk , pp. 9-12
- Petricciani, J.C.¹

2
- 0004900456
- Cell substrate issues - A historical perspective
- Edited by Hopps H, Petricciani J. Gaithersburg: Tissue Culture Association
- (1985) Abnormal Cells, New Products, and Risk , pp. 13-17
- Hopps, H.E.¹

3
- 0003299746
- Safety considerations for cell culture-derived biologicals
- Edited by Lyderson B. Munich: Hanser
- (1987) Large Scale Cell Culture Technology , pp. 232-247
- Lubiniecki, A.S.¹

4
- 0014382538
- Cells, vaccines, and the pursuit of precedent
- (1968) National Cancer Institute Monogr , vol.29 , pp. 463-468
- Hilleman, M.R.¹

5
- 0004902939
- Homotransplantation of human cell lines
- (1957) Science , vol.125 , pp. 158-160
- Southam, C.M.¹ Moore, A.E.² Rhoads, C.P.³

6
- 0001150406
- Transplantable human neoplasms maintained in cortisone-treated laboratory animals
- (1954) Cancer Res , vol.14 , pp. 660-665
- Toolan, H.W.¹

7
- 0023474361
- Risk of neoplastic transformation from cellular DNA: Calculations using the oncogene model
- Edited by Petricciani J, Hennessen W. Basel: Karger
- (1987) Cells, Products, Safety. Developments in Biological Standardization , vol.68 , pp. 43-49
- Petricciani, J.P.¹ Regan, P.J.²

8
- 0023461452
- Potential risks of tumor virus subgenomes in the production of biologicals
- Edited by Petricciani J, Hennessen W. Basel: Karger
- (1987) Cells, Products, Safety. Developments in Biological Standardization , vol.68 , pp. 51-62
- Moyer, M.P.¹ Moyer, R.C.²

9
- 0023484205
- Potential oncogenic hazards posed by oncogene encoded proteins
- Edited by Petricciani J, Hennessen W. Basel: Karger
- (1987) Cells, Products, Safety. Developments in Biological Standardization , vol.68 , pp. 63-67
- Lowy, D.R.¹

10
- 0033249682
- Cell substrates: Lessons learned and challenges remaining
- Edited by Brown F, Griffiths E, Horaud F, Schild GC. Basel: Karger
- (1999) A Celebration of 50 Years of Progress in Biological Standardization and Control at WHO. Developments in Biological Standardization , vol.100 , pp. 57-63
- Petricciani, J.C.¹

11
- 0004909014
- Characterization and uses of human diploid cells strains
- (1963) Nature , vol.200 , pp. 1161
- Hayflick, L.¹ Perkins, F.T.² Stevenson, R.E.³

12
- 12444251109
- European Medicines Evaluation Agency, CPMP/BWP/1143/00, London
- (2001) Position statement on the use of tumorigenic cells of human origin for the production of biological and biotechnological medicinal products

13
- 0004848827
- Continuously cultured tissue cells and viral vaccines
- (1963) Science , vol.139 , pp. 15-20
- Scherp, H.W.¹ Bryan, W.R.² Dawe, C.J.³ Earle, W.R.⁴ Habel, K.⁵ Huebner, R.J.⁶ Reinhard, K.⁷ Smadel, J.E.⁸

14
- 0028693397
- Assessing genetic stability at the nucleic acid level
- Edited by Brown F, Lubiniecki AS. Basel: Karger
- (1994) Genetic Stability and Recombinant Product Consistency , vol.83 , pp. 27-30
- Galibert, F.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.